Prescriber is the leading UK journal for healthcare professionals focussing on prescribing and medicines management. The journal features articles on all areas of therapeutics and prescribing policy and is fully peer reviewed. The content is relevant and of interest to all prescribers and prescribing policy makers including GPs, pharmacists, nurses and hospital specialists. Access to all content is free to healthcare professionals following registration.
Latest News
Latest QOF report shows increase in general practice achievement
NHS Digital has published its 2017–18 Quality and Outcomes Framework (QOF) report on the prevalence of conditions managed in primary care in England and the...Read more
ESPAUR report shows continuing decline in primary care antibiotic prescribing
The English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) has published its fifth annual report on antimicrobial resistance and...Read more
NICE publishes new antimicrobial prescribing guidance for urinary tract infections
NICE has published two new antimicrobial prescribing guidelines on the management of urinary tract infections (UTIs) – one for lower UTIs (also known as...Read more
Adalimumab biosimilars launched in the EU
Four new adalimumab biosimilar medicines have recently been launched in the EU. Amgevita (Amgen), Imraldi (Biogen), Hyrimoz (Sandoz) and Hulio (Mylan) are all...Read more
EMA restricts fluoroquinolone and quinolone prescribing
In light of reports of rare but disabling side-effects of fluoroquinolone and quinolones, the EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) has...Read more
Featured Articles
Prevalence, identification and harms of alcohol use disorders
In the first of a two-part series on the management of alcohol use disorders (AUDs), this article discusses the prevalence of AUDs, the harms associated with alcohol misuse and how to identify and assess patients in the primary care setting.
Click here to view
Tackling the growing problem of antifungal resistance
Until relatively recently, resistance to antifungal drugs has gone largely unreported in mainstream media, unlike the extensive coverage of resistance to antibiotics. However, we are now being warned that the consequences of antifungal resistance for human health, as well as our food supplies, could be serious unless action is taken. Here, we look at the extent of the problem and what is being done to combat it.
Click here to view
The Lancet Asthma Commission: treating children in primary care
The Asthma Commission, published in The Lancet in September 2017, challenged current principles and called for a new approach to the diagnosis and treatment of asthma. Here, two of the Commission’s authors discuss what primary care needs to know about their recommendations on the management of children with asthma.
Click here to view
